Top Ophthalmic Viscoelastic Devices Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Ophthalmic Viscoelastic Devices Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Ophthalmic Viscoelastic Devices industry players.

Ophthalmic Viscoelastic Devices Market Competitive Landscape

The competitive landscape of the global ophthalmic viscoelastic devices industry is marked by strategic collaborations, product innovation, and acquisitions among leading players aiming to strengthen their global presence and surgical portfolios. Major companies like Alcon, Johnson & Johnson Vision, and Bausch + Lomb continue to lead the market by leveraging strong distribution networks and introducing advanced viscoelastic formulations tailored for evolving surgical needs.

As per market strategies, in January 2024, Rayner acquired Sophi, a Swiss surgical technology firm, to expand its offerings in cataract surgery by integrating Sophi’s cutting-edge phacoemulsification systems with its intraocular lens portfolio.

Emerging startups in the ophthalmic viscoelastic devices market are focusing on innovative materials and advanced technologies to improve surgical outcomes. These new entrants are developing smart, biodegradable viscoelastic agents and leveraging AI-driven formulation methods to enhance precision, safety, and efficiency during eye surgeries. Their goal is to address unmet clinical needs while making high-quality ophthalmic care more accessible globally.

  • OcuNanoMed (Founded in 2021): OcuNanoMed is a medtech startup focused on revolutionizing viscoelastic formulations through nanotechnology and smart material science. The company develops advanced OVDs designed to dynamically respond to intraocular environments during surgery, enhancing surgical precision and patient safety. Its biodegradable and pressure-sensitive viscoelastic agents aim to minimize post-operative complications while maximizing surgical control, particularly in complex cataract and glaucoma procedures.
  • VisiBio Therapeutics (Founded in 2022): VisiBio Therapeutics concentrates on developing bioengineered ophthalmic solutions with a strong emphasis on biocompatibility and sustained intraocular protection. The startup is exploring AI-powered formulation techniques to design highly transparent, retention-optimized viscoelastic agents that can be customized based on surgical requirements. With a vision to make premium eye care more accessible, VisiBio is actively partnering with surgical centers and academic institutions across North America and Europe.

Top Player’s Company Profiles

  • Rayner Intraocular Lenses Limited
  • Nordic Group B.V.
  • Seikagaku Corporation
  • Alcon Inc.
  • Johnson & Johnson Vision
  • Bausch + Lomb
  • Carl Zeiss Meditec AG
  • BVI Medical
  • Hoya Corporation
  • Carl Zeiss AG
  • Santen Pharmaceutical Co., Ltd.
  • Croma-Pharma GmbH
  • Ophtechnics Unlimited

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Ophthalmic Viscoelastic Devices Market size was valued at USD 11.72 Billion in 2024 and is poised to grow from USD 13.08 Billion in 2025 to USD 31.47 Billion by 2033, growing at a CAGR of 11.6% during the forecast period (2026–2033).

The competitive landscape of the global ophthalmic viscoelastic devices industry is marked by strategic collaborations, product innovation, and acquisitions among leading players aiming to strengthen their global presence and surgical portfolios. Major companies like Alcon, Johnson & Johnson Vision, and Bausch + Lomb continue to lead the market by leveraging strong distribution networks and introducing advanced viscoelastic formulations tailored for evolving surgical needs. 'Alcon (Switzerland) ', 'Bausch + Lomb (Bausch Health) (USA) ', 'Carl Zeiss Meditec AG (Germany) ', 'Johnson & Johnson Vision (USA) ', 'Rayner Intraocular Lenses Limited (UK) ', 'Bohus Biotech AB (Sweden) ', 'Lifecore Biomedical LLC (USA) ', 'Hoya Corporation (Japan) ', 'Santen Pharmaceutical Co., Ltd. (Japan) ', 'Croma-Pharma GmbH (Austria) ', 'Eyekon Medical Inc. (USA) ', 'RUMEX International Co. (USA) ', 'Ziemer Ophthalmic Systems AG (Switzerland) ', 'Ophtechnics Unlimited (India) ', 'Haohai Biological Technology (China) ', 'Amring Pharmaceutical Inc. (USA) ', 'Truviz Ophthalmic (USA) ', 'Cima Technology Inc. (USA)'

Globally, the incidence of eye-related conditions such as cataracts, glaucoma, and age-related macular degeneration is increasing, largely driven by the aging population and lifestyle factors. These diseases often necessitate surgical interventions where ophthalmic viscoelastic devices are essential to protect the eye’s delicate tissues, maintain space, and facilitate the surgical process. As the number of patients undergoing such procedures grows, so does the demand for high-quality viscoelastic devices, directly fueling market expansion.

Integration of AI and Digital Technologies: Artificial intelligence is increasingly being integrated into ophthalmic surgery workflows, enhancing preoperative planning, intraoperative guidance, and postoperative care. AI-driven imaging and surgical assistance allow for more precise application of viscoelastic devices, minimizing risks and improving surgical outcomes. This technological synergy is leading to higher adoption rates of viscoelastic devices compatible with these advanced systems.

North America is a leading region in the ophthalmic viscoelastic devices market, driven by its advanced healthcare infrastructure and widespread adoption of innovative medical technologies. The high prevalence of eye disorders such as cataracts and glaucoma, combined with increasing awareness about vision care, fuels demand for effective surgical devices. Robust healthcare spending and supportive reimbursement policies further accelerate market growth. The presence of major medical device manufacturers and extensive clinical research also contribute to the strong position of this region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Global Ophthalmic Viscoelastic Devices Market
Ophthalmic Viscoelastic Devices Market

Report ID: SQMIG35A3046

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE